Insider · CIK 0001334682
Gregg H Alton
Files at NVAX (NOVAVAX INC), CORT (CORCEPT THERAPEUTICS INC). First filing -, latest -.
In brief
Gregg H Alton files SEC Form 4 as director at NVAX (NOVAVAX INC), and also at CORT (CORCEPT THERAPEUTICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gregg H Alton has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2026 | NVAX NOVAVAX INC | MOption exercise Common Stock | +18,880 | - | - | 47,685 | Jun 23, 2026 |
| Jun 18, 2026 | NVAX NOVAVAX INC | AGrant or award Stock Option (Right to Buy)derivative | +21,270 | $0.00 | $0 | 21,270 | Jun 23, 2026 |
| Jun 18, 2026 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +14,180 | $0.00 | $0 | 14,180 | Jun 23, 2026 |
| Jun 20, 2026 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -18,880 | $0.00 | $0 | 0 | Jun 23, 2026 |
| May 21, 2026 | CORT CORCEPT THERAPEUTICS INC | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | May 26, 2026 |
| Jun 20, 2025 | NVAX NOVAVAX INC | AGrant or award Stock Option (Right to Buy)derivative | +28,326 | $6.42 | $182k | 28,326 | Jun 24, 2025 |
| Jun 20, 2025 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +18,884 | $0.00 | $0 | 18,884 | Jun 24, 2025 |
| Jun 12, 2025 | NVAX NOVAVAX INC | MOption exercise Common Stock | +10,420 | $0.00 | $0 | 28,805 | Jun 16, 2025 |
| Jun 12, 2025 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -10,420 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 10, 2025 | CORT CORCEPT THERAPEUTICS INC | AGrant or award Stock option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 12, 2025 |
| Mar 31, 2024 | NVAX NOVAVAX INC | AGrant or award Common Stock | +3,420 | $4.90 | $17k | 7,220 | Feb 5, 2025 |
| Jun 30, 2024 | NVAX NOVAVAX INC | AGrant or award Common Stock | +1,202 | $13.93 | $17k | 15,092 | Feb 5, 2025 |
| Sep 30, 2024 | NVAX NOVAVAX INC | AGrant or award Common Stock | +1,311 | $12.77 | $17k | 16,403 | Feb 5, 2025 |
| Dec 31, 2024 | NVAX NOVAVAX INC | AGrant or award Common Stock | +1,982 | $8.61 | $17k | 18,385 | Feb 5, 2025 |
Questions about Gregg H Alton
Answered from the filings on this page, as of the latest one.
Is Gregg H Alton buying or selling?
Gregg H Alton has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gregg H Alton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregg H Alton has 0.
Where does Gregg H Alton file Form 4?
Gregg H Alton has filed Form 4 at NVAX (NOVAVAX INC); CORT (CORCEPT THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.